Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
45,497
archived clinical trials in
Breast Cancer

Gabapentin With or Without Antidepressants in Treating Hot Flashes in Women Who Have Had Breast Cancer or Have Concerns About Taking Hormone Therapy
A Phase III Randomized, Trial of Gabapentin Alone or in Conjunction With an Antidepressant in the Management of Hot Flashes in Women Who Have Inadequate Control With an Antidepressant Alone
Status: Enrolling
Updated:  7/7/2015
Green Bay Oncology, Limited at St. Mary's Hospital
mi
from
Green Bay, WI
Gabapentin With or Without Antidepressants in Treating Hot Flashes in Women Who Have Had Breast Cancer or Have Concerns About Taking Hormone Therapy
A Phase III Randomized, Trial of Gabapentin Alone or in Conjunction With an Antidepressant in the Management of Hot Flashes in Women Who Have Inadequate Control With an Antidepressant Alone
Status: Enrolling
Updated: 7/7/2015
Green Bay Oncology, Limited at St. Mary's Hospital
mi
from
Green Bay, WI
Click here to add this to my saved trials
Gabapentin With or Without Antidepressants in Treating Hot Flashes in Women Who Have Had Breast Cancer or Have Concerns About Taking Hormone Therapy
A Phase III Randomized, Trial of Gabapentin Alone or in Conjunction With an Antidepressant in the Management of Hot Flashes in Women Who Have Inadequate Control With an Antidepressant Alone
Status: Enrolling
Updated:  7/7/2015
St. Mary's Hospital Medical Center
mi
from
Green Bay, WI
Gabapentin With or Without Antidepressants in Treating Hot Flashes in Women Who Have Had Breast Cancer or Have Concerns About Taking Hormone Therapy
A Phase III Randomized, Trial of Gabapentin Alone or in Conjunction With an Antidepressant in the Management of Hot Flashes in Women Who Have Inadequate Control With an Antidepressant Alone
Status: Enrolling
Updated: 7/7/2015
St. Mary's Hospital Medical Center
mi
from
Green Bay, WI
Click here to add this to my saved trials
Gabapentin With or Without Antidepressants in Treating Hot Flashes in Women Who Have Had Breast Cancer or Have Concerns About Taking Hormone Therapy
A Phase III Randomized, Trial of Gabapentin Alone or in Conjunction With an Antidepressant in the Management of Hot Flashes in Women Who Have Inadequate Control With an Antidepressant Alone
Status: Enrolling
Updated:  7/7/2015
Green Bay Oncology, Limited - Oconto Falls
mi
from
Oconto Falls, WI
Gabapentin With or Without Antidepressants in Treating Hot Flashes in Women Who Have Had Breast Cancer or Have Concerns About Taking Hormone Therapy
A Phase III Randomized, Trial of Gabapentin Alone or in Conjunction With an Antidepressant in the Management of Hot Flashes in Women Who Have Inadequate Control With an Antidepressant Alone
Status: Enrolling
Updated: 7/7/2015
Green Bay Oncology, Limited - Oconto Falls
mi
from
Oconto Falls, WI
Click here to add this to my saved trials
Gabapentin With or Without Antidepressants in Treating Hot Flashes in Women Who Have Had Breast Cancer or Have Concerns About Taking Hormone Therapy
A Phase III Randomized, Trial of Gabapentin Alone or in Conjunction With an Antidepressant in the Management of Hot Flashes in Women Who Have Inadequate Control With an Antidepressant Alone
Status: Enrolling
Updated:  7/7/2015
Green Bay Oncology, Limited - Sturgeon Bay
mi
from
Sturgeon Bay, WI
Gabapentin With or Without Antidepressants in Treating Hot Flashes in Women Who Have Had Breast Cancer or Have Concerns About Taking Hormone Therapy
A Phase III Randomized, Trial of Gabapentin Alone or in Conjunction With an Antidepressant in the Management of Hot Flashes in Women Who Have Inadequate Control With an Antidepressant Alone
Status: Enrolling
Updated: 7/7/2015
Green Bay Oncology, Limited - Sturgeon Bay
mi
from
Sturgeon Bay, WI
Click here to add this to my saved trials
Gabapentin With or Without Antidepressants in Treating Hot Flashes in Women Who Have Had Breast Cancer or Have Concerns About Taking Hormone Therapy
A Phase III Randomized, Trial of Gabapentin Alone or in Conjunction With an Antidepressant in the Management of Hot Flashes in Women Who Have Inadequate Control With an Antidepressant Alone
Status: Enrolling
Updated:  7/7/2015
Welch Cancer Center
mi
from
Sheridan, WY
Gabapentin With or Without Antidepressants in Treating Hot Flashes in Women Who Have Had Breast Cancer or Have Concerns About Taking Hormone Therapy
A Phase III Randomized, Trial of Gabapentin Alone or in Conjunction With an Antidepressant in the Management of Hot Flashes in Women Who Have Inadequate Control With an Antidepressant Alone
Status: Enrolling
Updated: 7/7/2015
Welch Cancer Center
mi
from
Sheridan, WY
Click here to add this to my saved trials
ICI 182780 in Treating Women With Metastatic Breast Cancer
Phase II Trial Of Fulvestrant (Faslodex) In Women With Metastatic Breast Cancer And Failure on Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/9/2015
MBCCOP - Gulf Coast
mi
from
Mobile, AL
ICI 182780 in Treating Women With Metastatic Breast Cancer
Phase II Trial Of Fulvestrant (Faslodex) In Women With Metastatic Breast Cancer And Failure on Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/9/2015
MBCCOP - Gulf Coast
mi
from
Mobile, AL
Click here to add this to my saved trials
ICI 182780 in Treating Women With Metastatic Breast Cancer
Phase II Trial Of Fulvestrant (Faslodex) In Women With Metastatic Breast Cancer And Failure on Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/9/2015
CCOP - Mayo Clinic Scottsdale Oncology Program
mi
from
Scottsdale, AZ
ICI 182780 in Treating Women With Metastatic Breast Cancer
Phase II Trial Of Fulvestrant (Faslodex) In Women With Metastatic Breast Cancer And Failure on Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/9/2015
CCOP - Mayo Clinic Scottsdale Oncology Program
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
ICI 182780 in Treating Women With Metastatic Breast Cancer
Phase II Trial Of Fulvestrant (Faslodex) In Women With Metastatic Breast Cancer And Failure on Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/9/2015
Mayo Clinic
mi
from
Jacksonville, FL
ICI 182780 in Treating Women With Metastatic Breast Cancer
Phase II Trial Of Fulvestrant (Faslodex) In Women With Metastatic Breast Cancer And Failure on Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/9/2015
Mayo Clinic
mi
from
Jacksonville, FL
Click here to add this to my saved trials
ICI 182780 in Treating Women With Metastatic Breast Cancer
Phase II Trial Of Fulvestrant (Faslodex) In Women With Metastatic Breast Cancer And Failure on Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/9/2015
CCOP - Illinois Oncology Research Association
mi
from
Peoria, IL
ICI 182780 in Treating Women With Metastatic Breast Cancer
Phase II Trial Of Fulvestrant (Faslodex) In Women With Metastatic Breast Cancer And Failure on Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/9/2015
CCOP - Illinois Oncology Research Association
mi
from
Peoria, IL
Click here to add this to my saved trials
ICI 182780 in Treating Women With Metastatic Breast Cancer
Phase II Trial Of Fulvestrant (Faslodex) In Women With Metastatic Breast Cancer And Failure on Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/9/2015
Carle Foundation Hospital/ Carle Cancer Center
mi
from
Urbana, IL
ICI 182780 in Treating Women With Metastatic Breast Cancer
Phase II Trial Of Fulvestrant (Faslodex) In Women With Metastatic Breast Cancer And Failure on Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/9/2015
Carle Foundation Hospital/ Carle Cancer Center
mi
from
Urbana, IL
Click here to add this to my saved trials
ICI 182780 in Treating Women With Metastatic Breast Cancer
Phase II Trial Of Fulvestrant (Faslodex) In Women With Metastatic Breast Cancer And Failure on Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/9/2015
CCOP - Cedar Rapids Oncology Project
mi
from
Cedar Rapids, IA
ICI 182780 in Treating Women With Metastatic Breast Cancer
Phase II Trial Of Fulvestrant (Faslodex) In Women With Metastatic Breast Cancer And Failure on Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/9/2015
CCOP - Cedar Rapids Oncology Project
mi
from
Cedar Rapids, IA
Click here to add this to my saved trials
ICI 182780 in Treating Women With Metastatic Breast Cancer
Phase II Trial Of Fulvestrant (Faslodex) In Women With Metastatic Breast Cancer And Failure on Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/9/2015
CCOP - Iowa Oncology Research Association
mi
from
Des Moines, IA
ICI 182780 in Treating Women With Metastatic Breast Cancer
Phase II Trial Of Fulvestrant (Faslodex) In Women With Metastatic Breast Cancer And Failure on Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/9/2015
CCOP - Iowa Oncology Research Association
mi
from
Des Moines, IA
Click here to add this to my saved trials
ICI 182780 in Treating Women With Metastatic Breast Cancer
Phase II Trial Of Fulvestrant (Faslodex) In Women With Metastatic Breast Cancer And Failure on Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/9/2015
Siouxland Hematology-Oncology
mi
from
Sioux City, IA
ICI 182780 in Treating Women With Metastatic Breast Cancer
Phase II Trial Of Fulvestrant (Faslodex) In Women With Metastatic Breast Cancer And Failure on Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/9/2015
Siouxland Hematology-Oncology
mi
from
Sioux City, IA
Click here to add this to my saved trials
ICI 182780 in Treating Women With Metastatic Breast Cancer
Phase II Trial Of Fulvestrant (Faslodex) In Women With Metastatic Breast Cancer And Failure on Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/9/2015
CCOP - Wichita
mi
from
Wichita, KA
ICI 182780 in Treating Women With Metastatic Breast Cancer
Phase II Trial Of Fulvestrant (Faslodex) In Women With Metastatic Breast Cancer And Failure on Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/9/2015
CCOP - Wichita
mi
from
Wichita, KA
Click here to add this to my saved trials
ICI 182780 in Treating Women With Metastatic Breast Cancer
Phase II Trial Of Fulvestrant (Faslodex) In Women With Metastatic Breast Cancer And Failure on Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/9/2015
CCOP - Michigan Cancer Research Consortium
mi
from
Ann Arbor, MI
ICI 182780 in Treating Women With Metastatic Breast Cancer
Phase II Trial Of Fulvestrant (Faslodex) In Women With Metastatic Breast Cancer And Failure on Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/9/2015
CCOP - Michigan Cancer Research Consortium
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
ICI 182780 in Treating Women With Metastatic Breast Cancer
Phase II Trial Of Fulvestrant (Faslodex) In Women With Metastatic Breast Cancer And Failure on Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/9/2015
CCOP - Duluth
mi
from
Duluth, MN
ICI 182780 in Treating Women With Metastatic Breast Cancer
Phase II Trial Of Fulvestrant (Faslodex) In Women With Metastatic Breast Cancer And Failure on Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/9/2015
CCOP - Duluth
mi
from
Duluth, MN
Click here to add this to my saved trials
ICI 182780 in Treating Women With Metastatic Breast Cancer
Phase II Trial Of Fulvestrant (Faslodex) In Women With Metastatic Breast Cancer And Failure on Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/9/2015
Mayo Clinic Cancer Center
mi
from
Rochester, MN
ICI 182780 in Treating Women With Metastatic Breast Cancer
Phase II Trial Of Fulvestrant (Faslodex) In Women With Metastatic Breast Cancer And Failure on Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/9/2015
Mayo Clinic Cancer Center
mi
from
Rochester, MN
Click here to add this to my saved trials
ICI 182780 in Treating Women With Metastatic Breast Cancer
Phase II Trial Of Fulvestrant (Faslodex) In Women With Metastatic Breast Cancer And Failure on Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/9/2015
CCOP - Metro-Minnesota
mi
from
Saint Louis Park, MN
ICI 182780 in Treating Women With Metastatic Breast Cancer
Phase II Trial Of Fulvestrant (Faslodex) In Women With Metastatic Breast Cancer And Failure on Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/9/2015
CCOP - Metro-Minnesota
mi
from
Saint Louis Park, MN
Click here to add this to my saved trials
ICI 182780 in Treating Women With Metastatic Breast Cancer
Phase II Trial Of Fulvestrant (Faslodex) In Women With Metastatic Breast Cancer And Failure on Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/9/2015
CCOP - Missouri Valley Cancer Consortium
mi
from
Omaha, NE
ICI 182780 in Treating Women With Metastatic Breast Cancer
Phase II Trial Of Fulvestrant (Faslodex) In Women With Metastatic Breast Cancer And Failure on Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/9/2015
CCOP - Missouri Valley Cancer Consortium
mi
from
Omaha, NE
Click here to add this to my saved trials
ICI 182780 in Treating Women With Metastatic Breast Cancer
Phase II Trial Of Fulvestrant (Faslodex) In Women With Metastatic Breast Cancer And Failure on Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/9/2015
Medcenter One Health System
mi
from
Bismarck, ND
ICI 182780 in Treating Women With Metastatic Breast Cancer
Phase II Trial Of Fulvestrant (Faslodex) In Women With Metastatic Breast Cancer And Failure on Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/9/2015
Medcenter One Health System
mi
from
Bismarck, ND
Click here to add this to my saved trials
ICI 182780 in Treating Women With Metastatic Breast Cancer
Phase II Trial Of Fulvestrant (Faslodex) In Women With Metastatic Breast Cancer And Failure on Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/9/2015
CCOP - Merit Care Hospital
mi
from
Fargo, ND
ICI 182780 in Treating Women With Metastatic Breast Cancer
Phase II Trial Of Fulvestrant (Faslodex) In Women With Metastatic Breast Cancer And Failure on Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/9/2015
CCOP - Merit Care Hospital
mi
from
Fargo, ND
Click here to add this to my saved trials
ICI 182780 in Treating Women With Metastatic Breast Cancer
Phase II Trial Of Fulvestrant (Faslodex) In Women With Metastatic Breast Cancer And Failure on Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/9/2015
Altru Cancer Center
mi
from
Grand Forks, ND
ICI 182780 in Treating Women With Metastatic Breast Cancer
Phase II Trial Of Fulvestrant (Faslodex) In Women With Metastatic Breast Cancer And Failure on Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/9/2015
Altru Cancer Center
mi
from
Grand Forks, ND
Click here to add this to my saved trials
ICI 182780 in Treating Women With Metastatic Breast Cancer
Phase II Trial Of Fulvestrant (Faslodex) In Women With Metastatic Breast Cancer And Failure on Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/9/2015
CCOP - Toledo Community Hospital
mi
from
Toledo, OH
ICI 182780 in Treating Women With Metastatic Breast Cancer
Phase II Trial Of Fulvestrant (Faslodex) In Women With Metastatic Breast Cancer And Failure on Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/9/2015
CCOP - Toledo Community Hospital
mi
from
Toledo, OH
Click here to add this to my saved trials
ICI 182780 in Treating Women With Metastatic Breast Cancer
Phase II Trial Of Fulvestrant (Faslodex) In Women With Metastatic Breast Cancer And Failure on Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/9/2015
CCOP - Geisinger Clinic and Medical Center
mi
from
Danville, PA
ICI 182780 in Treating Women With Metastatic Breast Cancer
Phase II Trial Of Fulvestrant (Faslodex) In Women With Metastatic Breast Cancer And Failure on Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/9/2015
CCOP - Geisinger Clinic and Medical Center
mi
from
Danville, PA
Click here to add this to my saved trials
ICI 182780 in Treating Women With Metastatic Breast Cancer
Phase II Trial Of Fulvestrant (Faslodex) In Women With Metastatic Breast Cancer And Failure on Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/9/2015
Allegheny General Hospital
mi
from
Pittsburgh, PA
ICI 182780 in Treating Women With Metastatic Breast Cancer
Phase II Trial Of Fulvestrant (Faslodex) In Women With Metastatic Breast Cancer And Failure on Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/9/2015
Allegheny General Hospital
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
ICI 182780 in Treating Women With Metastatic Breast Cancer
Phase II Trial Of Fulvestrant (Faslodex) In Women With Metastatic Breast Cancer And Failure on Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/9/2015
CCOP - Upstate Carolina
mi
from
Spartanburg, SC
ICI 182780 in Treating Women With Metastatic Breast Cancer
Phase II Trial Of Fulvestrant (Faslodex) In Women With Metastatic Breast Cancer And Failure on Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/9/2015
CCOP - Upstate Carolina
mi
from
Spartanburg, SC
Click here to add this to my saved trials
ICI 182780 in Treating Women With Metastatic Breast Cancer
Phase II Trial Of Fulvestrant (Faslodex) In Women With Metastatic Breast Cancer And Failure on Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/9/2015
Rapid City Regional Hospital
mi
from
Rapid City, SD
ICI 182780 in Treating Women With Metastatic Breast Cancer
Phase II Trial Of Fulvestrant (Faslodex) In Women With Metastatic Breast Cancer And Failure on Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/9/2015
Rapid City Regional Hospital
mi
from
Rapid City, SD
Click here to add this to my saved trials
ICI 182780 in Treating Women With Metastatic Breast Cancer
Phase II Trial Of Fulvestrant (Faslodex) In Women With Metastatic Breast Cancer And Failure on Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/9/2015
CCOP - Sioux Community Cancer Consortium
mi
from
Sioux Falls, SD
ICI 182780 in Treating Women With Metastatic Breast Cancer
Phase II Trial Of Fulvestrant (Faslodex) In Women With Metastatic Breast Cancer And Failure on Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/9/2015
CCOP - Sioux Community Cancer Consortium
mi
from
Sioux Falls, SD
Click here to add this to my saved trials
ICI 182780 in Treating Women With Metastatic Breast Cancer
Phase II Trial Of Fulvestrant (Faslodex) In Women With Metastatic Breast Cancer And Failure on Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/9/2015
CCOP - St. Vincent Hospital Cancer Center, Green Bay
mi
from
Green Bay, WI
ICI 182780 in Treating Women With Metastatic Breast Cancer
Phase II Trial Of Fulvestrant (Faslodex) In Women With Metastatic Breast Cancer And Failure on Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/9/2015
CCOP - St. Vincent Hospital Cancer Center, Green Bay
mi
from
Green Bay, WI
Click here to add this to my saved trials
ICI 182780 in Treating Women With Metastatic Breast Cancer
Phase II Trial Of Fulvestrant (Faslodex) In Women With Metastatic Breast Cancer And Failure on Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/9/2015
Allan Blair Cancer Centre
mi
from
Regina,
ICI 182780 in Treating Women With Metastatic Breast Cancer
Phase II Trial Of Fulvestrant (Faslodex) In Women With Metastatic Breast Cancer And Failure on Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/9/2015
Allan Blair Cancer Centre
mi
from
Regina,
Click here to add this to my saved trials
Vinorelbine in Treating Older Women With Stage IV Breast Cancer
Phase II Trial of Oral Vinorelbine for the Treatment of Metastatic Breast Cancer in Patients >65 Years of Age: A Trial of Efficacy, Toxicity, and Patients' Perceived Preference for Oral Therapy
Status: Enrolling
Updated:  7/9/2015
CCOP - Scottsdale Oncology Program
mi
from
Scottsdale, AZ
Vinorelbine in Treating Older Women With Stage IV Breast Cancer
Phase II Trial of Oral Vinorelbine for the Treatment of Metastatic Breast Cancer in Patients >65 Years of Age: A Trial of Efficacy, Toxicity, and Patients' Perceived Preference for Oral Therapy
Status: Enrolling
Updated: 7/9/2015
CCOP - Scottsdale Oncology Program
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Vinorelbine in Treating Older Women With Stage IV Breast Cancer
Phase II Trial of Oral Vinorelbine for the Treatment of Metastatic Breast Cancer in Patients >65 Years of Age: A Trial of Efficacy, Toxicity, and Patients' Perceived Preference for Oral Therapy
Status: Enrolling
Updated:  7/9/2015
CCOP - Illinois Oncology Research Association
mi
from
Peoria, IL
Vinorelbine in Treating Older Women With Stage IV Breast Cancer
Phase II Trial of Oral Vinorelbine for the Treatment of Metastatic Breast Cancer in Patients >65 Years of Age: A Trial of Efficacy, Toxicity, and Patients' Perceived Preference for Oral Therapy
Status: Enrolling
Updated: 7/9/2015
CCOP - Illinois Oncology Research Association
mi
from
Peoria, IL
Click here to add this to my saved trials
Vinorelbine in Treating Older Women With Stage IV Breast Cancer
Phase II Trial of Oral Vinorelbine for the Treatment of Metastatic Breast Cancer in Patients >65 Years of Age: A Trial of Efficacy, Toxicity, and Patients' Perceived Preference for Oral Therapy
Status: Enrolling
Updated:  7/9/2015
CCOP - Carle Cancer Center
mi
from
Urbana, IL
Vinorelbine in Treating Older Women With Stage IV Breast Cancer
Phase II Trial of Oral Vinorelbine for the Treatment of Metastatic Breast Cancer in Patients >65 Years of Age: A Trial of Efficacy, Toxicity, and Patients' Perceived Preference for Oral Therapy
Status: Enrolling
Updated: 7/9/2015
CCOP - Carle Cancer Center
mi
from
Urbana, IL
Click here to add this to my saved trials
Vinorelbine in Treating Older Women With Stage IV Breast Cancer
Phase II Trial of Oral Vinorelbine for the Treatment of Metastatic Breast Cancer in Patients >65 Years of Age: A Trial of Efficacy, Toxicity, and Patients' Perceived Preference for Oral Therapy
Status: Enrolling
Updated:  7/9/2015
CCOP - Cedar Rapids Oncology Project
mi
from
Cedar Rapids, IA
Vinorelbine in Treating Older Women With Stage IV Breast Cancer
Phase II Trial of Oral Vinorelbine for the Treatment of Metastatic Breast Cancer in Patients >65 Years of Age: A Trial of Efficacy, Toxicity, and Patients' Perceived Preference for Oral Therapy
Status: Enrolling
Updated: 7/9/2015
CCOP - Cedar Rapids Oncology Project
mi
from
Cedar Rapids, IA
Click here to add this to my saved trials
Vinorelbine in Treating Older Women With Stage IV Breast Cancer
Phase II Trial of Oral Vinorelbine for the Treatment of Metastatic Breast Cancer in Patients >65 Years of Age: A Trial of Efficacy, Toxicity, and Patients' Perceived Preference for Oral Therapy
Status: Enrolling
Updated:  7/9/2015
CCOP - Iowa Oncology Research Association
mi
from
Des Moines, IA
Vinorelbine in Treating Older Women With Stage IV Breast Cancer
Phase II Trial of Oral Vinorelbine for the Treatment of Metastatic Breast Cancer in Patients >65 Years of Age: A Trial of Efficacy, Toxicity, and Patients' Perceived Preference for Oral Therapy
Status: Enrolling
Updated: 7/9/2015
CCOP - Iowa Oncology Research Association
mi
from
Des Moines, IA
Click here to add this to my saved trials
Vinorelbine in Treating Older Women With Stage IV Breast Cancer
Phase II Trial of Oral Vinorelbine for the Treatment of Metastatic Breast Cancer in Patients >65 Years of Age: A Trial of Efficacy, Toxicity, and Patients' Perceived Preference for Oral Therapy
Status: Enrolling
Updated:  7/9/2015
Siouxland Hematology-Oncology
mi
from
Sioux City, IA
Vinorelbine in Treating Older Women With Stage IV Breast Cancer
Phase II Trial of Oral Vinorelbine for the Treatment of Metastatic Breast Cancer in Patients >65 Years of Age: A Trial of Efficacy, Toxicity, and Patients' Perceived Preference for Oral Therapy
Status: Enrolling
Updated: 7/9/2015
Siouxland Hematology-Oncology
mi
from
Sioux City, IA
Click here to add this to my saved trials
Vinorelbine in Treating Older Women With Stage IV Breast Cancer
Phase II Trial of Oral Vinorelbine for the Treatment of Metastatic Breast Cancer in Patients >65 Years of Age: A Trial of Efficacy, Toxicity, and Patients' Perceived Preference for Oral Therapy
Status: Enrolling
Updated:  7/9/2015
CCOP - Wichita
mi
from
Wichita, KA
Vinorelbine in Treating Older Women With Stage IV Breast Cancer
Phase II Trial of Oral Vinorelbine for the Treatment of Metastatic Breast Cancer in Patients >65 Years of Age: A Trial of Efficacy, Toxicity, and Patients' Perceived Preference for Oral Therapy
Status: Enrolling
Updated: 7/9/2015
CCOP - Wichita
mi
from
Wichita, KA
Click here to add this to my saved trials
Vinorelbine in Treating Older Women With Stage IV Breast Cancer
Phase II Trial of Oral Vinorelbine for the Treatment of Metastatic Breast Cancer in Patients >65 Years of Age: A Trial of Efficacy, Toxicity, and Patients' Perceived Preference for Oral Therapy
Status: Enrolling
Updated:  7/9/2015
CCOP - Ann Arbor Regional
mi
from
Ann Arbor, MI
Vinorelbine in Treating Older Women With Stage IV Breast Cancer
Phase II Trial of Oral Vinorelbine for the Treatment of Metastatic Breast Cancer in Patients >65 Years of Age: A Trial of Efficacy, Toxicity, and Patients' Perceived Preference for Oral Therapy
Status: Enrolling
Updated: 7/9/2015
CCOP - Ann Arbor Regional
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Vinorelbine in Treating Older Women With Stage IV Breast Cancer
Phase II Trial of Oral Vinorelbine for the Treatment of Metastatic Breast Cancer in Patients >65 Years of Age: A Trial of Efficacy, Toxicity, and Patients' Perceived Preference for Oral Therapy
Status: Enrolling
Updated:  7/9/2015
CCOP - Duluth
mi
from
Duluth, MN
Vinorelbine in Treating Older Women With Stage IV Breast Cancer
Phase II Trial of Oral Vinorelbine for the Treatment of Metastatic Breast Cancer in Patients >65 Years of Age: A Trial of Efficacy, Toxicity, and Patients' Perceived Preference for Oral Therapy
Status: Enrolling
Updated: 7/9/2015
CCOP - Duluth
mi
from
Duluth, MN
Click here to add this to my saved trials
Vinorelbine in Treating Older Women With Stage IV Breast Cancer
Phase II Trial of Oral Vinorelbine for the Treatment of Metastatic Breast Cancer in Patients >65 Years of Age: A Trial of Efficacy, Toxicity, and Patients' Perceived Preference for Oral Therapy
Status: Enrolling
Updated:  7/9/2015
Mayo Clinic Cancer Center
mi
from
Rochester, MN
Vinorelbine in Treating Older Women With Stage IV Breast Cancer
Phase II Trial of Oral Vinorelbine for the Treatment of Metastatic Breast Cancer in Patients >65 Years of Age: A Trial of Efficacy, Toxicity, and Patients' Perceived Preference for Oral Therapy
Status: Enrolling
Updated: 7/9/2015
Mayo Clinic Cancer Center
mi
from
Rochester, MN
Click here to add this to my saved trials
Vinorelbine in Treating Older Women With Stage IV Breast Cancer
Phase II Trial of Oral Vinorelbine for the Treatment of Metastatic Breast Cancer in Patients >65 Years of Age: A Trial of Efficacy, Toxicity, and Patients' Perceived Preference for Oral Therapy
Status: Enrolling
Updated:  7/9/2015
CentraCare Health Plaza
mi
from
Saint Cloud, MN
Vinorelbine in Treating Older Women With Stage IV Breast Cancer
Phase II Trial of Oral Vinorelbine for the Treatment of Metastatic Breast Cancer in Patients >65 Years of Age: A Trial of Efficacy, Toxicity, and Patients' Perceived Preference for Oral Therapy
Status: Enrolling
Updated: 7/9/2015
CentraCare Health Plaza
mi
from
Saint Cloud, MN
Click here to add this to my saved trials
Vinorelbine in Treating Older Women With Stage IV Breast Cancer
Phase II Trial of Oral Vinorelbine for the Treatment of Metastatic Breast Cancer in Patients >65 Years of Age: A Trial of Efficacy, Toxicity, and Patients' Perceived Preference for Oral Therapy
Status: Enrolling
Updated:  7/9/2015
CCOP - Metro-Minnesota
mi
from
Saint Louis Park, MN
Vinorelbine in Treating Older Women With Stage IV Breast Cancer
Phase II Trial of Oral Vinorelbine for the Treatment of Metastatic Breast Cancer in Patients >65 Years of Age: A Trial of Efficacy, Toxicity, and Patients' Perceived Preference for Oral Therapy
Status: Enrolling
Updated: 7/9/2015
CCOP - Metro-Minnesota
mi
from
Saint Louis Park, MN
Click here to add this to my saved trials
Vinorelbine in Treating Older Women With Stage IV Breast Cancer
Phase II Trial of Oral Vinorelbine for the Treatment of Metastatic Breast Cancer in Patients >65 Years of Age: A Trial of Efficacy, Toxicity, and Patients' Perceived Preference for Oral Therapy
Status: Enrolling
Updated:  7/9/2015
CCOP - Missouri Valley Cancer Consortium
mi
from
Omaha, NE
Vinorelbine in Treating Older Women With Stage IV Breast Cancer
Phase II Trial of Oral Vinorelbine for the Treatment of Metastatic Breast Cancer in Patients >65 Years of Age: A Trial of Efficacy, Toxicity, and Patients' Perceived Preference for Oral Therapy
Status: Enrolling
Updated: 7/9/2015
CCOP - Missouri Valley Cancer Consortium
mi
from
Omaha, NE
Click here to add this to my saved trials
Vinorelbine in Treating Older Women With Stage IV Breast Cancer
Phase II Trial of Oral Vinorelbine for the Treatment of Metastatic Breast Cancer in Patients >65 Years of Age: A Trial of Efficacy, Toxicity, and Patients' Perceived Preference for Oral Therapy
Status: Enrolling
Updated:  7/9/2015
Medcenter One Health System
mi
from
Bismarck, ND
Vinorelbine in Treating Older Women With Stage IV Breast Cancer
Phase II Trial of Oral Vinorelbine for the Treatment of Metastatic Breast Cancer in Patients >65 Years of Age: A Trial of Efficacy, Toxicity, and Patients' Perceived Preference for Oral Therapy
Status: Enrolling
Updated: 7/9/2015
Medcenter One Health System
mi
from
Bismarck, ND
Click here to add this to my saved trials
Vinorelbine in Treating Older Women With Stage IV Breast Cancer
Phase II Trial of Oral Vinorelbine for the Treatment of Metastatic Breast Cancer in Patients >65 Years of Age: A Trial of Efficacy, Toxicity, and Patients' Perceived Preference for Oral Therapy
Status: Enrolling
Updated:  7/9/2015
Altru Health Systems
mi
from
Grand Forks, ND
Vinorelbine in Treating Older Women With Stage IV Breast Cancer
Phase II Trial of Oral Vinorelbine for the Treatment of Metastatic Breast Cancer in Patients >65 Years of Age: A Trial of Efficacy, Toxicity, and Patients' Perceived Preference for Oral Therapy
Status: Enrolling
Updated: 7/9/2015
Altru Health Systems
mi
from
Grand Forks, ND
Click here to add this to my saved trials
Vinorelbine in Treating Older Women With Stage IV Breast Cancer
Phase II Trial of Oral Vinorelbine for the Treatment of Metastatic Breast Cancer in Patients >65 Years of Age: A Trial of Efficacy, Toxicity, and Patients' Perceived Preference for Oral Therapy
Status: Enrolling
Updated:  7/9/2015
CCOP - Geisinger Clinic and Medical Center
mi
from
Danville, PA
Vinorelbine in Treating Older Women With Stage IV Breast Cancer
Phase II Trial of Oral Vinorelbine for the Treatment of Metastatic Breast Cancer in Patients >65 Years of Age: A Trial of Efficacy, Toxicity, and Patients' Perceived Preference for Oral Therapy
Status: Enrolling
Updated: 7/9/2015
CCOP - Geisinger Clinic and Medical Center
mi
from
Danville, PA
Click here to add this to my saved trials
Vinorelbine in Treating Older Women With Stage IV Breast Cancer
Phase II Trial of Oral Vinorelbine for the Treatment of Metastatic Breast Cancer in Patients >65 Years of Age: A Trial of Efficacy, Toxicity, and Patients' Perceived Preference for Oral Therapy
Status: Enrolling
Updated:  7/9/2015
Rapid City Regional Hospital
mi
from
Rapid City, SD
Vinorelbine in Treating Older Women With Stage IV Breast Cancer
Phase II Trial of Oral Vinorelbine for the Treatment of Metastatic Breast Cancer in Patients >65 Years of Age: A Trial of Efficacy, Toxicity, and Patients' Perceived Preference for Oral Therapy
Status: Enrolling
Updated: 7/9/2015
Rapid City Regional Hospital
mi
from
Rapid City, SD
Click here to add this to my saved trials
Vinorelbine in Treating Older Women With Stage IV Breast Cancer
Phase II Trial of Oral Vinorelbine for the Treatment of Metastatic Breast Cancer in Patients >65 Years of Age: A Trial of Efficacy, Toxicity, and Patients' Perceived Preference for Oral Therapy
Status: Enrolling
Updated:  7/9/2015
CCOP - Sioux Community Cancer Consortium
mi
from
Sioux Falls, SD
Vinorelbine in Treating Older Women With Stage IV Breast Cancer
Phase II Trial of Oral Vinorelbine for the Treatment of Metastatic Breast Cancer in Patients >65 Years of Age: A Trial of Efficacy, Toxicity, and Patients' Perceived Preference for Oral Therapy
Status: Enrolling
Updated: 7/9/2015
CCOP - Sioux Community Cancer Consortium
mi
from
Sioux Falls, SD
Click here to add this to my saved trials
Erlotinib and Gemcitabine in Treating Patients With Metastatic Breast Cancer Previously Treated With An Anthracycline and/or a Taxane
A Phase II Study of OSI-774 (Tarceva) and Gemcitabine for Patients With Metastatic Breast Cancer
Status: Enrolling
Updated:  7/9/2015
CCOP - Mayo Clinic Scottsdale Oncology Program
mi
from
Scottsdale, AZ
Erlotinib and Gemcitabine in Treating Patients With Metastatic Breast Cancer Previously Treated With An Anthracycline and/or a Taxane
A Phase II Study of OSI-774 (Tarceva) and Gemcitabine for Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 7/9/2015
CCOP - Mayo Clinic Scottsdale Oncology Program
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Erlotinib and Gemcitabine in Treating Patients With Metastatic Breast Cancer Previously Treated With An Anthracycline and/or a Taxane
A Phase II Study of OSI-774 (Tarceva) and Gemcitabine for Patients With Metastatic Breast Cancer
Status: Enrolling
Updated:  7/9/2015
Mayo Clinic, Jacksonville
mi
from
Jacksonville, FL
Erlotinib and Gemcitabine in Treating Patients With Metastatic Breast Cancer Previously Treated With An Anthracycline and/or a Taxane
A Phase II Study of OSI-774 (Tarceva) and Gemcitabine for Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 7/9/2015
Mayo Clinic, Jacksonville
mi
from
Jacksonville, FL
Click here to add this to my saved trials